Đang chuẩn bị liên kết để tải về tài liệu:
Profound tumor-specific Th2 bias in patients with malignant glioma

Vaccination against tumor-associated antigens is one promising approach to immunotherapy against malignant gliomas. While previous vaccine efforts have focused exclusively on HLA class I-restricted peptides, class II-restricted peptides are necessary to induce CD4+ helper T cells and sustain effective anti-tumor immunity. |